FIELD: oncology.
SUBSTANCE: invention relates to a compound represented by the formula 15 or 18, or its pharmaceutically acceptable salt. The invention relates to a pharmaceutical composition having anticancer activity and containing an effective amount of a compound of formulas 15 and 18 or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier. The invention also relates to the use of the compound according to the invention to obtain a drug for the treatment, attenuation, reduction of severity, reduction of risk of developing or suppressing cancer and to obtain a drug for the treatment of a tumor or tumors with drug resistance.
EFFECT: technical result is compounds interacting with the binding site of cochicin, having anticancer activity.
14 cl, 12 dwg, 4 tbl, 7 ex
. 
, 
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATING CANCER | 2015 |
|
RU2733393C2 |
| COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
| COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
| COMPOUNDS FOR CANCER TREATMENT | 2011 |
|
RU2762111C1 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| COMPOUND FOR TREATING CANCER | 2014 |
|
RU2708247C2 |
| SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
| ANDROGEN RECEPTOR SELECTIVE DESTROYING (SARD) LIGANDS AND METHODS OF THEIR USE | 2017 |
|
RU2795431C2 |
| ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
| PHENYL-GUANIDINE DERIVATIVES | 2012 |
|
RU2612533C2 |
